The life sciences industry – pharmaceuticals, medical devices, diagnostics, vaccines and related businesses – is huge, growing and global, with international licensing, sales contracts, research and development agreements, and joint ventures.
Veranstaltungsart: Seminar
- Standort:
- Charles River Associates, 200 Clarendon Street, Floor 9 , Boston MA
- Startdatum / -uhrzeit:
- 10 April 2019
- Enddatum / -uhrzeit:
- 10 April 2019
Each of these international ventures can lead to disputes, and well-positioned life sciences companies prefer international arbitration to litigation as the practical way to achieve confidential, widely enforceable judgments in a neutral setting.
Listen in as our distinguished panel of speakers explain why international arbitration is the preferred dispute resolution mechanism for life sciences disputes, before they take a deeper dive into some of the complex issues that can arise in such disputes.